2005
DOI: 10.1111/j.1365-2222.2005.02252.x
|View full text |Cite
|
Sign up to set email alerts
|

The promiscuity of immunoglobulin E binding to peanut allergens, as determined by Western blotting, correlates with the severity of clinical symptoms

Abstract: Promiscuity of IgE binding appears more important than the recognition of individual proteins. This may mean that clinically useful specific immunotherapy for peanut allergy will be difficult to achieve if only selected allergenic proteins are used. Further investigation of Ara h 1 and 3/4 subunits and a possible association with symptom severity are also highlighted by this study.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
46
1
1

Year Published

2007
2007
2020
2020

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(53 citation statements)
references
References 28 publications
5
46
1
1
Order By: Relevance
“…2) a predominant role of this protein in the allergenic response to lupin, which is in agreement with previous reports (Holden et al, 2008;Moneret-Vautrin et al, 1999). Moreover, the protein alignments have shown that the IgE-binding lupin peptides from a-conglutin and b-conglutin are highly homologous to allergic peanut peptides reported in literature (Lewis et al, 2005;van Boxtel et al, 2008), highlighting several conserved epitopes recognised by IgE antibodies. In a recent work of our group a lupin protein isolate was submitted to industrial food processing with the aim to study the change of the protein bio-availability before and after strong thermal treatments (Sirtori et al, 2010).…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…2) a predominant role of this protein in the allergenic response to lupin, which is in agreement with previous reports (Holden et al, 2008;Moneret-Vautrin et al, 1999). Moreover, the protein alignments have shown that the IgE-binding lupin peptides from a-conglutin and b-conglutin are highly homologous to allergic peanut peptides reported in literature (Lewis et al, 2005;van Boxtel et al, 2008), highlighting several conserved epitopes recognised by IgE antibodies. In a recent work of our group a lupin protein isolate was submitted to industrial food processing with the aim to study the change of the protein bio-availability before and after strong thermal treatments (Sirtori et al, 2010).…”
Section: Discussionsupporting
confidence: 88%
“…The peptides identified in the reactive spots were aligned against known allergenic peptides (Lewis, Grimshaw, Warner, & Hourihane, 2005;van Boxtel, Koppelman, van den Broek, & Gruppen, 2008) belonging to the major peanut allergens. Supplementary Table IV summarises the results of the alignments obtained with the BLASTp Program: allergen Ara h 1 was aligned against b-conglutin precursor, vicilin-like protein and b-conglutin showing an identity between 50% and 76% and a homology between 63% and 93%.…”
Section: Identification Of Reactive Lupin Proteins By Western Blottinmentioning
confidence: 99%
“…Peeters et al 78 used purified peanut proteins (Ara h 1-3, Ara h 6) and found a correlation of clinical severity with recognition of Ara h 2 and 6 at low concentrations, and Ara h 1 and 3 at higher concentrations, indicating apparent increased potency of Ara h 2, also noted by Palmer et al 79 Astier et al 80 used recombinant peanut proteins, recombinant Ara h 1-3, and found binding was dominant to recombinant Ara h 2, but severity correlated with polysensitization. Indeed, a positive correlation of reaction severity with increased diversity of binding, whether to the allergens 78,81 or epitopes, 82 is a common theme that may translate to future diagnostic tests that can predict severity, likelihood of current allergy, and resolution.…”
Section: Present and Future Diagnostic Strategies/natural Coursementioning
confidence: 97%
“…Four studies (Hourihane et al, 1997;Wensing Marjolein et al, 2002;Lewis et al, 2005;Flinterman et al, 2006a) were specifically designed to assess LOAEL doses and provide accurate information on the doses tested (Taylor et al, 2009b).…”
Section: Minimum (Observed) Eliciting Dosesmentioning
confidence: 99%